Halling Anders, Fridh Gerd, Ovhed Ingvar
Blekinge Institute for Research & Development, Karlshamn, Sweden.
BMC Public Health. 2006 Jun 28;6:171. doi: 10.1186/1471-2458-6-171.
Individualbased measures for comorbidity are of increasing importance for planning and funding health care services. No measurement for individualbased healthcare costs exist in Sweden. The aim of this study was to validate the Johns Hopkins ACG Case-Mix System's predictive value of polypharmacy (regular use of 4 or more prescription medicines) used as a proxy for health care costs in an elderly population and to study if the prediction could be improved by adding variables from a population based study i.e. level of education, functional status indicators and health perception.
The Johns Hopkins ACG Case-Mix System was applied to primary health care diagnoses of 1402 participants (60-96 years) in a cross-sectional community based study in Karlskrona, Sweden (the Swedish National study on Ageing and Care) during a period of two years before they took part in the study. The predictive value of the Johns Hopkins ACG Case-Mix System was modeled against the regular use of 4 or more prescription medicines, also using age, sex, level of education, instrumental activity of daily living- and measures of health perception as covariates.
In an exploratory biplot analysis the Johns Hopkins ACG Case-Mix System, was shown to explain a large part of the variance for regular use of 4 or more prescription medicines. The sensitivity of the prediction was 31.9%, whereas the specificity was 88.5%, when the Johns Hopkins ACG Case-Mix System was adjusted for age. By adding covariates to the model the sensitivity was increased to 46.3%, with a specificity of 90.1%. This increased the number of correctly classified by 5.6% and the area under the curve by 11.1%.
The Johns Hopkins ACG Case-Mix System is an important factor in measuring comorbidity, however it does not reflect an individual's capability to function despite a disease burden, which has importance for prediction of comorbidity. In this study we have shown that information on such factors, which can be obtained from short questionnaires increases the probability to correctly predict an individual's use of resources, such as medications.
基于个体的共病测量对于医疗服务的规划和资金投入愈发重要。瑞典不存在基于个体的医疗费用测量方法。本研究的目的是验证约翰霍普金斯ACG病例组合系统对老年人群中多药联用(常规使用4种或更多处方药)作为医疗费用替代指标的预测价值,并研究通过纳入基于人群研究的变量(即教育水平、功能状态指标和健康认知)是否可以改善预测。
在瑞典卡尔斯克鲁纳进行的一项基于社区的横断面研究(瑞典老龄化与护理全国研究)中,约翰霍普金斯ACG病例组合系统被应用于1402名参与者(60 - 96岁)在参与研究前两年的初级医疗保健诊断。约翰霍普金斯ACG病例组合系统的预测价值以常规使用4种或更多处方药为模型,同时将年龄、性别、教育水平、日常生活工具性活动以及健康认知测量作为协变量。
在探索性双标图分析中,约翰霍普金斯ACG病例组合系统显示能解释常规使用4种或更多处方药差异的很大一部分。当约翰霍普金斯ACG病例组合系统根据年龄进行调整时,预测的敏感性为31.9%,而特异性为88.5%。通过在模型中加入协变量,敏感性提高到46.3%,特异性为90.1%。这使得正确分类的数量增加了5.6%,曲线下面积增加了11.1%。
约翰霍普金斯ACG病例组合系统是测量共病的一个重要因素,然而它并未反映个体在疾病负担下的功能能力,而这对于共病预测很重要。在本研究中我们表明,可以从简短问卷中获得的此类因素信息增加了正确预测个体资源使用(如药物)的概率。